With reference to the notice of Board Meeting dated October 31 2023 we hereby inform that the Board of Directors at its Meeting held on November 07 2023 (commenced at 11.25 a.m. and concluded at 11.55 a.m.) has inter alia approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30 2023.In view of the aforesaid we are enclosing Annexure I - Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30 2023 along with the Limited Review report issued by MSKA & Associates Statutory Auditors of the Company as an Annexure.The aforesaid financial results and other documents are also being uploaded on the website of the Company i.e. www.advancedenzymes.comThis is for your information and for public at large.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
